Research Portfolio

We have been funding research since 2012. Explore our timeline of research projects below, or browse our Current or Completed project pages.

Key

Gene therapy and Gene editing

Cell therapy

Drug therapy

Protein therapy

EB cancer therapy

Research

2026

Healome

Development of an eye treatment for ocular surface damage

Read more

Chemoprevention of RDEB SCC

Chemoprevention of recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma

Read more

Replay

Replay next-generation gene therapy for DEB

Read more

ELK-003

An opthalmic solution for the treatment of corneal abrasions associated with epidermolysis bullosa

Read more

mRNA-based base editing

Evaluation of long-term effect on skin homeostasis and regeneration in a RDEB mouse model using different delivery methods of LNPs encapsulating mRNA-based base editing approach

Read more

Bespoke Therapy for RDEB

Bespoke antisense oligomer-mediated splice modulating therapies for Recessive Dystrophic Epidermolysis Bullosa patients

Read more

Therapy for JEB Airway Disease

Towards cell and gene therapy for Junctional Epidermolysis Bullosa airway disease

Read more

2025

Nova Anchora

Development of NvA-011 for topical application in Dystrophic Epidermolysis Bullosa

Read more

Base & Prime Editing for RDEB

Base and prime editing strategies for Recessive Dystrophic Epidermolysis Bullosa

Read more

Gene & Cell Therapy in RDEB SCC

Gene & Cell Therapy in Recessive Dystrophic Epidermolysis Squamous Cell Carcinoma

Read more